316 related articles for article (PubMed ID: 29439865)
21. Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions.
Hyun H; Jang AY; Suh JW; Bae IG; Choi WS; Seo YB; Lee J; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Kim MJ; Song JY
J Korean Med Sci; 2023 Oct; 38(42):e330. PubMed ID: 37904655
[TBL] [Abstract][Full Text] [Related]
22. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
[TBL] [Abstract][Full Text] [Related]
23. Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay.
Pletz MW; Ewig S; Rohde G; Schuette H; Rupp J; Welte T; Suttorp N; Forstner C;
Vaccine; 2016 Apr; 34(20):2342-8. PubMed ID: 27016653
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
[TBL] [Abstract][Full Text] [Related]
25. Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UK.
Hyams C; Lahuerta M; Theilacker C; King J; Adegbite D; McGuinness S; Grimes C; Campling J; Southern J; Pride MW; Begier E; Maskell N; Oliver J; Jodar L; Gessner BD; Finn A;
Vaccine; 2024 Mar; 42(7):1599-1607. PubMed ID: 38336560
[TBL] [Abstract][Full Text] [Related]
26. Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status.
Rodrigo C; Bewick T; Sheppard C; Greenwood S; Macgregor V; Trotter C; Slack M; George R; Lim WS
Thorax; 2014 Feb; 69(2):168-73. PubMed ID: 24048505
[TBL] [Abstract][Full Text] [Related]
27. Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis.
McLaughlin JM; Jiang Q; Gessner BD; Swerdlow DL; Sings HL; Isturiz RE; Jodar L
Vaccine; 2019 Oct; 37(43):6310-6316. PubMed ID: 31522807
[TBL] [Abstract][Full Text] [Related]
28. Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands.
Vestjens SMT; Wagenvoort GHJ; Grutters JC; Meek B; Aldenkamp AF; Vlaminckx BJM; Bos WJW; Rijkers GT; van de Garde EMW
Vaccine; 2017 Jul; 35(33):4112-4118. PubMed ID: 28668570
[TBL] [Abstract][Full Text] [Related]
29. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
30. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.
Bewick T; Sheppard C; Greenwood S; Slack M; Trotter C; George R; Lim WS
Thorax; 2012 Jun; 67(6):540-5. PubMed ID: 22374921
[TBL] [Abstract][Full Text] [Related]
31. The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia.
Gessner BD; Isturiz R; Snow V; Grant LR; Theilacker C; Jodar L
Expert Rev Vaccines; 2021 Mar; 20(3):269-280. PubMed ID: 33602035
[No Abstract] [Full Text] [Related]
32. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study.
Menéndez R; España PP; Pérez-Trallero E; Uranga A; Méndez R; Cilloniz C; Marimón JM; Cifuentes I; Méndez C; Torres A
Vaccine; 2017 Sep; 35(39):5264-5270. PubMed ID: 28823622
[TBL] [Abstract][Full Text] [Related]
33. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
34. Multicountry Review of Streptococcus pneumoniae Serotype Distribution Among Adults With Community-Acquired Pneumonia.
Grant LR; Begier E; Theilacker C; Barry R; Hall-Murray C; Yan Q; Pope V; Pride MW; Jodar L; Gessner BD
J Infect Dis; 2024 Jan; 229(1):282-293. PubMed ID: 37665210
[TBL] [Abstract][Full Text] [Related]
35. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
[TBL] [Abstract][Full Text] [Related]
36. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan.
Nakashima K; Suzuki K; Aoshima M; Murabata M; Kondo K; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2022 Nov; 40(46):6589-6598. PubMed ID: 36184405
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults.
Chalmers JD; Campling J; Dicker A; Woodhead M; Madhava H
BMC Pulm Med; 2016 May; 16(1):77. PubMed ID: 27169895
[TBL] [Abstract][Full Text] [Related]
39. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.
Torres A; Cillóniz C; Blasi F; Chalmers JD; Gaillat J; Dartois N; Schmitt HJ; Welte T
Respir Med; 2018 Apr; 137():6-13. PubMed ID: 29605214
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines.
Heo JY; Seo YB; Jeong HW; Choi MJ; Min KH; Choi WS; Lee J; Noh JY; Cheong HJ; Kim WJ; Song JY
Vaccine; 2020 Nov; 38(49):7747-7755. PubMed ID: 33164798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]